Skip to content

Clinical trials

Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: United States Clear all

313 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20042
20052
20062
20074
20083
20097
20102
20118
20128
20137
201417
201513
201611
201725
201817
201926
202025
202124
202224
202320
202424
202516
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Terminated76
Recruiting62
Active, not recruiting36
Unknown status12
Withdrawn10
Not yet recruiting4
Suspended2
Available2
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
Mayo Clinic14
M.D. Anderson Cancer Center9
Washington University School of Medicine8
Weill Medical College of Cornell University8
City of Hope Medical Center7
Memorial Sloan Kettering Cancer Center6
Stanford University5
Eli Lilly and Company4
Incyte Corporation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma313
Colorectal Neoplasms63
Pancreatic Neoplasms61
Carcinoma, Hepatocellular56
Gallbladder Neoplasms52
Stomach Neoplasms48
Bile Duct Neoplasms46
Ovarian Neoplasms44
Biliary Tract Neoplasms42
Liver Neoplasms42

Trials

Showing 76 to 100 of 313. Each trial links to its page on Pharma Observatory.

213 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.